14-day Premium Trial Subscription Try For FreeTry Free
$1.75
-0.0600 (-3.31%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.60 $5.47 Friday, 3rd May 2024 LGVN stock ended at $1.75. This is 3.31% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 8.67% from a day low at $1.73 to a day high of $1.88.
90 days $0.331 $5.47
52 weeks $0.331 $5.47

Historical Longeveron Inc. prices

Date Open High Low Close Volume
Feb 22, 2024 $0.501 $0.530 $0.501 $0.513 124 748
Feb 21, 2024 $0.537 $0.555 $0.513 $0.529 127 585
Feb 20, 2024 $0.530 $0.549 $0.513 $0.525 191 593
Feb 16, 2024 $0.516 $0.538 $0.516 $0.530 113 929
Feb 15, 2024 $0.541 $0.541 $0.515 $0.531 114 956
Feb 14, 2024 $0.520 $0.540 $0.500 $0.540 81 975
Feb 13, 2024 $0.530 $0.540 $0.500 $0.521 232 967
Feb 12, 2024 $0.540 $0.560 $0.528 $0.555 200 383
Feb 09, 2024 $0.510 $0.538 $0.510 $0.526 46 449
Feb 08, 2024 $0.521 $0.537 $0.491 $0.516 148 824
Feb 07, 2024 $0.514 $0.539 $0.506 $0.521 128 126
Feb 06, 2024 $0.530 $0.551 $0.510 $0.530 114 114
Feb 05, 2024 $0.564 $0.580 $0.526 $0.533 186 902
Feb 02, 2024 $0.535 $0.570 $0.510 $0.558 525 489
Feb 01, 2024 $0.546 $0.546 $0.473 $0.511 330 162
Jan 31, 2024 $0.543 $0.559 $0.500 $0.539 820 155
Jan 30, 2024 $0.580 $0.604 $0.418 $0.538 2 158 735
Jan 29, 2024 $0.750 $0.791 $0.652 $0.671 4 838 772
Jan 26, 2024 $0.80 $0.82 $0.750 $0.80 72 227
Jan 25, 2024 $0.82 $0.86 $0.760 $0.82 96 869
Jan 24, 2024 $0.89 $0.89 $0.82 $0.82 87 285
Jan 23, 2024 $0.89 $0.90 $0.82 $0.86 122 727
Jan 22, 2024 $0.91 $0.96 $0.84 $0.88 210 718
Jan 19, 2024 $1.01 $1.03 $0.94 $0.95 153 221
Jan 18, 2024 $1.09 $1.10 $0.95 $1.02 88 178
Click to get the best stock tips daily for free!

About Longeveron Inc.

Longeveron. Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, a... LGVN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT